+ Filter
Loading...
CD20 & CD22
Loading...Anti-CD20 & CD22 Products
- Anti-Human CD22 Recombinant Antibody (TAB-183-F(E)) (TAB-183-F(E))
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Fv - disulfide stabilized
- Application: FuncS, IF, Neut, ELISA, FC, IP, ICC
Compare
-
- Derivation: Humanized (from mouse)
- Species Reactivity: Human
- Type: Humanized (from mouse) IgG4, κ
- Application: ELISA, FC, IP, FuncS, IF, Neut, ICC
Compare
-
- Derivation: Humanized (from mouse)
- Species Reactivity: Human
- Type: IgG1
- Application: IF, IP, Neut, FuncS, ELISA, FC, ICC
Compare
- Human Anti-CD22 Recombinant Antibody (TAB-1717CL) (TAB-1717CL)
-
- Derivation: Human
- Type: Fully human antibody
- Application: Cyt, FuncS
Compare
- Human Anti-CD22 Recombinant Antibody (TAB-1718CL) (TAB-1718CL)
-
- Derivation: Human
- Type: Fully human antibody
- Application: Cyt, FuncS
Compare
- Human Anti-CD22 Recombinant Antibody (TAB-1719CL) (TAB-1719CL)
-
- Derivation: Human
- Type: Fully human antibody
- Application: ELISA
Compare
- Human Anti-CD22 Recombinant Antibody (TAB-1720CL) (TAB-1720CL)
-
- Derivation: Human
- Type: Fully human antibody
- Application: ELISA
Compare
- Human Anti-CD22 Recombinant Antibody (TAB-1721CL) (TAB-1721CL)
-
- Type: Human antibody
- Application: ELISA, FC, FuncS
Compare
- Human Anti-CD22 Recombinant Antibody (TAB-1722CL) (TAB-1722CL)
-
- Type: Human antibody
- Application: ELISA, FC, FuncS
Compare
- Human Anti-CD22 Recombinant Antibody (HPAB-0199-LSX) (HPAB-0199-LSX)
-
- Species Reactivity: Human
- Type: Human IgG1
- Application: ELISA, FC
Compare
- Mouse Anti-Human CD22 Recombinant Antibody (TAB-003LC)
-
- Application: FC
Compare
- Human Anti-CD22 Recombinant Antibody (TAB-1724CL) (TAB-1724CL)
-
- Derivation: Chimeric (mouse/human)
- Species Reactivity: Human
- Type: Chimeric (mouse/human) IgG1, κ
- Application: Inhib
Compare
- Human Anti-CD22 Recombinant Antibody Fab Fragment (TAB-1719CL-F(E)) (TAB-1719CL-F(E))
-
- Derivation: Human
- Type: Fully human antibody
Compare
- Mouse Anti-CD22 Recombinant Antibody (HPAB-0198-LSX) (HPAB-0198-LSX)
-
- Species Reactivity: Human, Cynomolgus monkey
- Type: Mouse IgG
- Application: ELISA, WB, IF, FC, SPR
Compare
- Human Anti-CD22 Recombinant Antibody Fab Fragment (TAB-1718CL-F(E)) (TAB-1718CL-F(E))
-
- Derivation: Human
- Type: Fully human antibody
Compare
- Anti-Human CD22 Recombinant Antibody (VM1000) (TAB-002LC)
-
- Derivation: Humanized
- Type: Humanized antibody
- Application: FC, ELISA, SPR, FuncS
Compare
- Anti-Human CD22 Recombinant Antibody scFv Fragment (hLL2) (TAB-0196CL-S(P))
-
- Application: ELISA, In vivo
Compare
- Anti-Human CD22 Recombinant Antibody scFv Fragment (hLL2-Cys) (TAB-0197CL-S(P))
-
- Application: ELISA, In vivo
Compare
- Anti-Human CD22 Recombinant Antibody Fab Fragment (hLL2) (TAB-0196CL-F(E))
-
- Application: ELISA, In vivo
Compare
- Anti-Human CD22 Recombinant Antibody Fab Fragment (hLL2-Cys) (TAB-0197CL-F(E))
-
- Application: ELISA, In vivo
Compare
- Mouse Anti-CD22 Recombinant Antibody; scFv Fragment (TAB-001LC-S(P)) (TAB-001LC-S(P))
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: ELISA
Compare
-
- Derivation: Humanized (from mouse)
- Species Reactivity: Human
- Type: Humanized (from mouse) IgG1, κ
- Application: FC, IP, ELISA, Neut, FuncS, IF, ICC
Compare
- Human Anti-CD22 Recombinant Antibody (TAB-001LC) (TAB-001LC)
-
- Derivation: Chimeric (mouse/human)
- Species Reactivity: Human
- Type: Chimeric antibody (mouse/human)
- Application: ELISA
Compare
- Human Anti-CD22 Recombinant Antibody (HPAB-0195-LSX) (HPAB-0195-LSX)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Human IgG
- Application: Apop, Cyt, FC, WB, Inhib, FuncS, IF, ELISA
Compare
- Human Anti-CD22 Recombinant Antibody Fab Fragment (TAB-1715CL-F(E)) (TAB-1715CL-F(E))
-
- Derivation: Human
- Type: Fully human antibody
Compare
- Mouse Anti-CD22 Recombinant Antibody (HPAB-0196-LSX) (HPAB-0196-LSX)
-
- Species Reactivity: Human
- Type: Mouse IgG
- Application: ELISA, FC, IP, RIA
Compare
- Human Anti-CD22 Recombinant Antibody Fab Fragment (TAB-1716CL-F(E)) (TAB-1716CL-F(E))
-
- Derivation: Human
- Type: Fully human antibody
Compare
- Human Anti-CD22 Recombinant Antibody (HPAB-0197-LSX) (HPAB-0197-LSX)
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Human IgG
- Application: ELISA, FC, FuncS
Compare
- Human Anti-CD22 Recombinant Antibody Fab Fragment (TAB-1717CL-F(E)) (TAB-1717CL-F(E))
-
- Derivation: Human
- Type: Fully human antibody
Compare
- Mouse Anti-CD22 Recombinant Antibody; scFv Fragment (TAB-1724CL-S(P)) (TAB-1724CL-S(P))
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: Inhib
Compare
- Human Anti-CD22 Recombinant Antibody; scFv Fragment (TAB-1725CL-S(P)) (TAB-1725CL-S(P))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized scFv
- Application: Block, Cyt, ELISA, FuncS
Compare
- Human Anti-CD22 Recombinant Antibody; scFv Fragment (TAB-1729CL-S(P)) (TAB-1729CL-S(P))
-
- Derivation: Humanized
- Species Reactivity: Human
- Type: Humanized scFv
- Application: IF, FC
Compare
- Human Anti-CD22 Recombinant Antibody (TAB-1715CL) (TAB-1715CL)
-
- Derivation: Human
- Type: Fully human antibody
- Application: Cyt, FuncS
Compare
- Human Anti-CD22 Recombinant Antibody (TAB-1716CL) (TAB-1716CL)
-
- Derivation: Human
- Type: Fully human antibody
- Application: Cyt, FuncS
Compare
- Anti-Human CD22 Recombinant Antibody (hLL2) (TAB-0196CL)
-
- Application: Inhib, Cyt, FC, WB
Compare
- Anti-Human CD22 Recombinant Antibody (hLL2-Cys) (TAB-0197CL)
-
- Application: ELISA, In vivo
Compare
- Human Anti-CD22 Recombinant Antibody scFv Fragment (TAB-1715CL-S(P)) (TAB-1715CL-S(P))
-
- Derivation: Human
- Type: Fully human antibody
Compare
- Human Anti-CD22 Recombinant Antibody scFv Fragment (TAB-1716CL-S(P)) (TAB-1716CL-S(P))
-
- Derivation: Human
- Type: Fully human antibody
Compare
- Human Anti-CD22 Recombinant Antibody scFv Fragment (TAB-1717CL-S(P)) (TAB-1717CL-S(P))
-
- Derivation: Human
- Type: Fully human antibody
Compare
- Human Anti-CD22 Recombinant Antibody scFv Fragment (TAB-1718CL-S(P)) (TAB-1718CL-S(P))
-
- Derivation: Human
- Type: Fully human antibody
Compare
- Human Anti-CD22 Recombinant Antibody scFv Fragment (TAB-1719CL-S(P)) (TAB-1719CL-S(P))
-
- Derivation: Human
- Type: Fully human antibody
Compare
- Human Anti-CD22 Recombinant Antibody scFv Fragment (TAB-1720CL-S(P)) (TAB-1720CL-S(P))
-
- Derivation: Human
- Type: Fully human antibody
Compare
- Human Anti-CD22 Recombinant Antibody scFv Fragment (TAB-1721CL-S(P)) (TAB-1721CL-S(P))
-
- Type: Human antibody
- Application: ELISA, FC, FuncS
Compare
- Human Anti-CD22 Recombinant Antibody scFv Fragment (TAB-1722CL-S(P)) (TAB-1722CL-S(P))
-
- Type: Human antibody
- Application: ELISA, FC, FuncS
Compare
- Mouse Anti-CD22 Recombinant Antibody; scFv Fragment (TAB-1723CL-S(P)) (TAB-1723CL-S(P))
-
- Species Reactivity: Human
- Type: Mouse scFv
- Application: Inhib
Compare
- Recombinant Anti-Human CD22 Antibody Fab Fragment (MOB-1248z-F(E))
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Fab
- Application: IP, RIA, FuncS
Compare
- Recombinant Anti-Human CD22 Antibody scFv Fragment (MOB-1248z-S(P))
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: scFv
- Application: ELISA, WB, IF, FuncS
Compare
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Fab' - G2a - kappa
- Application: ELISA, FC, IP, FuncS, IF, Neut, WB
Compare
- Mouse Anti-CD22 Recombinant Antibody; scFv Fragment (TAB-1714CL-S(P)) (TAB-1714CL-S(P))
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse scFv
- Application: ELISA, WB
Compare
- Mouse Anti-CD22 Recombinant Antibody (TAB-1714CL) (TAB-1714CL)
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse IgG
- Application: ELISA, WB
Compare
- Anti-Human CD22 Recombinant Antibody scFv Fragment (RFB4) (TAB-1728CL-S(P))
-
- Application: IF, FC
Compare
- Mouse Anti-CD22 Recombinant Antibody; Fab Fragment (TAB-1714CL-F(E)) (TAB-1714CL-F(E))
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse Fab
- Application: ELISA, WB
Compare
- Anti-CD22 immunotoxin RFB4 (IgG)-PE (AGTO-G077E)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
Compare
- Anti-CD22 immunotoxin RFB4 (IgG)-DT (AGTO-G077D)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
Compare
- anti-CD22 immunotoxin RFB4 (scFv)-PE (AGTO-L048E)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
Compare
- anti-CD22 immunotoxin RFB4 (scFv)-DT (AGTO-L048D)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
Compare
- anti-CD22 immunotoxin RFB4 (scFv)-Gel (AGTO-L048G)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
Compare
- anti-CD22 immunotoxin RFB4 (scFv)-RTA (AGTO-L048R)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
Compare
- anti-CD22 immunotoxin RFB4 (scFv)-Sap (AGTO-L048S)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Functional assay
Compare
- Anti-CD22 immunotoxin RFB4 (IgG)-Gel (AGTO-G077G)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
Compare
- Anti-CD22 immunotoxin RFB4 (IgG)-RTA (AGTO-G077R)
-
- Species Reactivity: Human
- Application: Cytotoxicity assay, Function study
Compare
- Anti-Human CD22 Recombinant Antibody (TAB-004LC)
-
- Application: FC
Compare
- Anti-CD22 (Pinatuzumab)-MC-VC-PABC-MMAE ADC (ADC-034LCT)
-
- Target: CD22
- Linker: MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MMAE (Monomethyl auristatin E)
Compare
- Anti-CD22-MCC-DM1 ADC (ADC-033LCT)
-
- Target: CD22
- Linker: mcc (Maleimidomethyl cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
Compare
- Anti-CD22 (clone hLL2)-SN-38 ADC (ADC-124CL)
-
- Target: CD22
- Drug: SN-38 (7-ethyl-10-hydroxycamptothecin)
Compare
- Anti-CD22 (clone 10F4v3)-BMPEO-DM1 ADC (ADC-211CL)
-
- Target: CD22
- Linker: BMPEO (bis-maleimido-trioxyethylene glycol)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
Compare
- Anti-CD22 (clone 10F4v3)-MC-MMAF ADC (ADC-212CL)
-
- Target: CD22
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
Compare
- Anti-CD22 (clone 10F4v3)-MC-vc-PAB-MMAE ADC (ADC-213CL)
-
- Target: CD22
- Linker: MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MMAE (Monomethyl auristatin E)
Compare
- Anti-CD22 (clone 5E8)-SMCC-DM1 ADC (ADC-214CL)
-
- Target: CD22
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
Compare
- Anti-CD22 (clone 7A2)-SMCC-DM1 ADC (ADC-215CL)
-
- Target: CD22
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
Compare
- Anti-CD22 (RFB4)-mcc-DM1 ADC (ADC-028LCT)
-
- Target: CD22
- Linker: mcc (Maleimidomethyl cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
Compare
- Anti-CD22 (10F4)-AcBut-Calicheamicin ADC (ADC-029LCT)
-
- Target: CD22
- Linker: AcBut
- Drug: Calicheamicin
Compare
- Anti-CD22-CL2A-SN-38 ADC (ADC-030LCT)
-
- Target: CD22
- Linker: CL2A
- Drug: SN-38 (7-ethyl-10-hydroxycamptothecin)
Compare
- Anti-CD22-CL2E-SN-38 ADC (ADC-031LCT)
-
- Target: CD22
- Linker: CL2E
- Drug: SN-38 (7-ethyl-10-hydroxycamptothecin)
Compare
- Anti-CD22 (clone G5/44)-AcBut-CalichDMH ADC (ADC-003LZY)
-
- Target: CD22
- Linker: AcBut (4-(4-acetylphenoxy)butanoic acid)
- Drug: CalichDMH
Compare
- Anti-CD22-AcBut-CalichDMH ADC (ADC-006LZY)
-
- Target: CD22
- Linker: AcBut (4-(4-acetylphenoxy)butanoic acid)
- Drug: CalichDMH
Compare
- Anti-CD22 (clone hu10F4)-MCC-DM1 ADC (ADC-027LZY)
-
- Target: CD22
- Linker: MCC (4-(N-maleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1(N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine)
Compare
- Anti-CD22-mc-vc-PABc-NMS249 ADC (ADC-097LZY)
-
- Target: CD22
- Linker: mc-VC-PABc (maleimidocaproyl valine-citrulline-p-aminobenzyl carbamoyl)
- Drug: NMS249
Compare
- Anti-CD22-mc-vc-PABc-MMAE ADC (ADC-033LZY)
-
- Target: CD22
- Linker: mc-VC-PABc(maleimidocaproyl valine-citrulline-p-aminobenzyl carbamoyl)
- Drug: MMAE (monomethyl auristatin E)
Compare
- Anti-CD22 (clone HB22.7)-saporin ADC (ADC-154LZY)
-
- Target: CD22
- Drug: saporin
Compare
- Anti-CD22 (clone 10F4v1)-SMCC-DM1 ADC (ADC-216CL)
-
- Target: CD22
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
Compare
- Anti-CD22 (clone 10F4v2)-SMCC-DM1 ADC (ADC-217CL)
-
- Target: CD22
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
Compare
- Anti-CD22 (clone 10F4v2)-MC-MMAF ADC (ADC-218CL)
-
- Target: CD22
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
Compare
- Anti-CD22 (clone 10F4v3)-SMCC-DM1 ADC (ADC-219CL)
-
- Target: CD22
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
Compare
- Anti-CD22 (clone 10F4v3)-MC-MMAF ADC (ADC-220CL)
-
- Target: CD22
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
Compare
- Anti-CD22 (clone 10F4v3)-SPP-DM1 ADC (ADC-221CL)
-
- Target: CD22
- Linker: SPP (N-succinimidyl-4-(2-pyridyldithio)pentanoate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
Compare
- Anti-CD22 (clone 10F4v3)-MC-vc-PAB-MMAE ADC (ADC-222CL)
-
- Target: CD22
- Linker: MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MMAE (Monomethyl auristatin E)
Compare
- Anti-CD22 (clone 10F4)-SMCC-DM1 ADC (ADC-223CL)
-
- Target: CD22
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
Compare
- Anti-CD22 (clone RFB4)-SMCC-DM1 ADC (ADC-224CL)
-
- Target: CD22
- Linker: SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate)
- Drug: DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine)
Compare
- Anti-CD22 (clone RFB4)-MC-vc-PAB-MMAF ADC (ADC-225CL)
-
- Target: CD22
- Linker: MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MMAF (Monomethyl auristatin F)
Compare
- Anti-CD22 (clone RFB4)-MC-MMAF ADC (ADC-226CL)
-
- Target: CD22
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
Compare
- Anti-CD22 (clone RFB4)-MC-vc-PAB-MMAE ADC (ADC-227CL)
-
- Target: CD22
- Linker: MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MMAE (Monomethyl auristatin E)
Compare
- Anti-CD22 (clone 10F4v3)-MC-vc-PAB-MMAE ADC (ADC-228CL)
-
- Target: CD22
- Linker: MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MMAE (Monomethyl auristatin E)
Compare
- Anti-CD22 (clone 10F4v1)-MC-MMAF ADC (ADC-229CL)
-
- Target: CD22
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
Compare
- Anti-CD22 (clone 10F4v3)-MC-vc-PAB-MMAE ADC (ADC-230CL)
-
- Target: CD22
- Linker: MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl)
- Drug: MMAE (Monomethyl auristatin E)
Compare
- Anti-CD22-MC-MMAF ADC (ADC-032LCT)
-
- Target: CD22
- Linker: Mc (maleimidocaproyl)
- Drug: MMAF (Monomethyl auristatin F)
Compare
View More Products
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
More Infomation
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
For Research Use Only. Not For Clinical Use.
Background
CD22 (CD22 Molecule) is a Protein Coding gene. Diseases associated with CD22 include refractory hematologic cancer and colon lymphoma. Among its related pathways are Immune System and Downstream signaling events of B Cell Receptor (BCR). GO annotations related to this gene include carbohydrate binding. An important paralog of this gene is VCAM1.
CD20 is a cell surface protein expressed on B cells. It is a common target for monoclonal antibody therapy in B-cell lymphomas and autoimmune diseases.
